Stay updated with breaking news from Nanocellect Biomedical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NanoCellect Biomedical, Inc. brought in $35 million in Series C and D funding to advance its microfluidic cell sorting solutions. Local investors such as FusionX Ventures, Anzu Partners and Agilent Technologies are among those backing the San Diego biotech.
Nanocellect Biomedical Welcomes Peter Vander Horn as Senior VP of Research & Development
/PRNewswire/ -- In the near future, the flow cytometry industry is poised to undergo remarkable advancements, driven by ongoing innovations in technology and...
During the forecast period. Increasing adoption of novel cellular assays in various cancer research applications is one of the key opportunities in the...
/PRNewswire/ -- The single-cell analysis industry is poised for remarkable advancements in the near future. Rapid progress in technology and innovative...